We sequenced and annotated the genomes of four P. vivax strains collected from disparate geographic locations, tripling the number of genome sequences available for this understudied parasite and providing the first genome-wide perspective of global variability in this species. We observe approximately twice as much SNP diversity among these isolates as we do among a comparable collection of isolates of P. falciparum, a malaria-causing parasite that results in higher mortality. This indicates a distinct history of global colonization and/or a more stable demographic history for P. vivax relative to P. falciparum, which is thought to have undergone a recent population bottleneck. The SNP diversity, as well as additional microsatellite and gene family variability, suggests a capacity for greater functional variation in the global population of P. vivax. These findings warrant a deeper survey of variation in P. vivax to equip disease interventions targeting the distinctive biology of this neglected but major pathogen.
Half the world's population is estimated to be at risk for malaria caused by P. vivax 1 , owing to this parasite's unique potential for lengthy remission and tolerance of cooler climates than those preferred by strictly tropical Plasmodium species. Although the P. falciparum parasite is responsible for the majority of contemporary malariarelated mortality, there is evidence that P. vivax may have been a more virulent parasite before the advent of modern medicine. As far north as England, death records indicate that P. vivax likely reduced the average lifespan from 58 to 33 years during the nineteenth century 2 . More recently, studies have shown that P. vivax is capable of causing the severe malaria syndromes that have long been attributed only to P. falciparum 3 .
In spite of the past and present impact of P. vivax on human health, it remains chronically understudied relative to P. falciparum. The ability to continuously culture P. falciparum but not P. vivax in the laboratory, compounded with the differential mortality imposed by the two species, has led to vast discrepancies in the state of knowledge regarding almost all aspects of the biology of these species. The recently renewed push for malaria eradication may remain incomplete unless this disparity in knowledge is addressed and the findings of new studies applied to disease control programs 4 .
Genetic diversity is important to characterize in order to understand the history of human association with a disease, to evaluate the direct effects of diversity on clinical disease and also because it may directly or indirectly reduce the efficacy of therapeutics such as drugs and vaccines. In contrast to P. falciparum, for which the genomes of many hundreds of isolates have now been sequenced or genotyped 5 , only the P. vivax genomic reference strain (Salvador I) 6 and unassembled shotgun sequencing of a Peruvian isolate (IQ07) 7 have been completed. We sequenced, assembled and annotated the genomes of four geographically disparate isolates of P. vivax to remedy the lack of genetic diversity data available for this species relative to P. falciparum. The designations and geographic origins of each P. vivax strain are given in Table 1 , which also lists the names and origins of a concurrently sequenced comparator panel of P. falciparum isolates that came from similarly disparate geographic locales. Templates of both species were sequenced using the same next-generation sequencing platform (Illumina Genome Analyzer IIx and HiSeq 2000) and evaluated for diversity using the same bioinformatic tools. All four of the newly sequenced P. vivax reference strains (North Korean, India VII, Mauritania I and Brazil I) are clonal infections adapted for growth in monkeys, are publically available via the Malaria Research and Reference Reagent Resource Center (MR4; see URLs) and were sequenced from genomic DNA derived from leukocytedepleted monkey blood (Online Methods). The P. falciparum isolates (from Honduras, India, Indochina (Thailand and Laos) and Senegal) were also clonal and were sequenced using template derived from in vitro cultures. We generated de novo assemblies for each of the four P. vivax isolates ( Table 2) using the ALLPATHS LG assembly algorithm 8 . Assembly quality was substantially higher for P. vivax
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum l e t t e r s than for a P. falciparum assembly generated using the same approach ( Supplementary Table 1 ), likely due to the more moderate AT nucleotide composition of the P. vivax genome (P. vivax: 57.7% AT versus P. falciparum: 80.6% AT). Synteny between the new P. vivax assemblies and the Salvador I reference assembly was found to be highly conserved (≥97.9%; Supplementary Fig. 1) .
We next used the sequencing data to evaluate genetic diversity within each species. The pairwise SNP rate for each sequenced isolate relative to the reference assembly for each species (P. vivax, Salvador I; P. falciparum, 3D7) is given in Figure 1a as a function of inferred SNP quality. Pairwise SNP rate relative to a reference assembly is expected to be a function of evolutionary or geographic distance, but, despite the varying geographic origin of isolates from both species, we found that the P. vivax SNP rates were uniformly higher than the P. falciparum SNP rates, regardless of the SNP quality threshold used. This finding suggests globally higher genetic diversity in P. vivax relative to P. falciparum, a genome-wide result confirming previous pilot surveys 9, 10 . We explored this finding by comparing mean SNP rates according to sequence class, using SNPs with a minimum PHREDstyle quality score of 30 (estimated accuracy of at least 99.9%) 11 . We found that P. vivax exhibited a significantly higher mean SNP rate than P. falciparum at intergenic and intronic fourfold-degenerate synonymous coding sites, within coding sequences overall and across all sequence classes (t test, P = 0.0087; Fig. 1b ), suggesting that the difference in diversity is pervasive and occurs across the genome. To control for variation in the degree of functional constraint among genes within each genome, we next evaluated mean pairwise SNP diversity (π) in a collection of 3,401 genes for which we could confidently identify 1:1 orthologs in the two species using the reciprocal best BLAST hits (RBH) criterion. In this comparison, we observed approximately twice as much SNP diversity in P. vivax compared to P. falciparum (paired t test, P = 2.2 × 10 −16 ; Fig. 1c ), confirming the ubiquity and magnitude of the SNP diversity disparity between the species ( Supplementary Fig. 2 and Supplementary Table 2) .
To test whether a differing SNP mutation rate, rather than a different effective population size and/or demographic history, can account for the differences in SNP diversity observed, we compared the genome-wide diversity of microsatellites, a different class of mutation. Because microsatellite length variants are caused by replication slippage rather than point substitution 12 , we would expect their relative diversity profile to be different from that of SNPs under the null hypothesis that a different point mutation rate explains the disparity in SNP diversity. We applied a new method of evaluating microsatellite length variation from Illumina data and observed, as we had with the SNPs, significantly higher diversity in P. vivax than in P. falciparum (bootstrapping, 279 and 22,713 microsatellites with at least 8 repeats in P. vivax and P. falciparum, respectively; P = 0.021; Fig. 1d and Supplementary Fig. 3) . Given the population genetic evidence that P. falciparum underwent multiple drug-induced selective sweeps and at least one significant bottleneck 13 , these results indicate that P. vivax may have a comparatively large effective population size due to an absence of such demographic events in recent history. Even in the face of common drug pressure, P. vivax may have disproportionate demographic stability due to its unique capacity for dormancy within infected hosts.
Our sample is smaller than is ideal for evaluating the time to the most recent common ancestor (TMRCA), but by comparing the deepest pairwise nucleotide divergence observed for each species at fourfold-degenerate synonymous sites (P. vivax: Mauritania versus Brazil I, 1.628 × 10 −3 substitutions per site; P. falciparum: 3D7 versus Dd2, 9.59 × 10 −4 substitutions per site) we can predict that the lower bound for TMRCA in P. vivax is approximately 70% greater than that for P. falciparum. The calculation of absolute TMRCA dates is dependent on the accuracy of the inferred mutation rate, and, therefore, results must be interpreted with caution. Nevertheless, if we assume a commonly accepted eukaryotic genome-wide mutation rate for fourfold-degenerate sites (2.2 × 10 −9 substitutions per site per year 14 , similar to a Plasmodium rate estimated with less precision) 15 , we can estimate the TMRCA as 768,000 and 452,000 years ago for P. vivax and P. falciparum, respectively. This P. vivax estimate is deeper than previous TMRCA estimates generated using a small number of loci in a larger population sample 16 , but reconciliation of the absolute estimates is difficult without knowledge of the true mutation rate. Assuming mutation rates are similar in both parasite lineages, however, the result stands that P. vivax has a much deeper TMRCA.
Other departures in the global population history of these two species are indicated by the topology and branch lengths of their respective phylograms (Fig. 2) . The relatively large degree of divergence between the IQ07 Peruvian isolate and the Brazil I and Salvador I strains of P. vivax suggests a distinct history in the New World relative to P. falciparum, which exhibits low diversity in the New World and is thought to have been introduced within the last 500 years via the African slave trade 17 . The high New World diversity of P. vivax, combined with the closer phylogenetic affinity of the three New World P. vivax isolates with the east Asian (North Korean) rather than the African (Mauritania I) or south Asian (India VII) strains, could suggest the precolonial arrival of P. vivax in the New World accompanying human dispersal from Asia by sea or, less likely, by the Bering land bridge during the last glacial maximum. Alternatively, this profile could be explained by recent but very large-scale (relative to P. falciparum) postcolonial introductions to the New World npg l e t t e r s via transoceanic trade from east Asia, the Pacific or Europe, the last of which presumably harbored a genetically distinct parasite clade before disease elimination 18 . Deeper genomic sampling of P. vivax populations will be required to explain these patterns in the diversity data. We next explored the profile of variation in individual genes and gene families to evaluate the potential functional consequences of the extremely high genomic diversity we observe in P. vivax. Mean pairwise divergence among the sequenced P. vivax isolates is highest in gene families associated with red blood cell invasion and immune evasion (Fig. 3a) . Functional enrichment analysis of diversity in individual genes also found nonsynonymous SNPs to be concentrated in invasion-related motility genes ( Supplementary Table 3 ). This extremely high sequence diversity suggests that vaccines targeting polymorphic antigens may encounter an even greater hurdle in eliciting cross-protective immune responses than they do in P. falciparum, where strain-specific immunity has been recently observed to limit vaccine efficacy 19 .
Differences in the distribution of nonsynonymous SNPs among genes with orthologs in both species are potentially reflective of differences in disease biology in P. vivax and P. falciparum (Supplementary Table 4 ). Genes expressed in the pre-erythrocytic stages are the most enriched group among those with higher ratios of nonsynonymousto-synonymous diversity (π NS /π S ) in P. vivax relative to P. falciparum (Mann-Whitney U test; Z score = 2.2), whereas genes associated with host-parasite interactions are the most enriched group with higher π NS /π S in P. falciparum relative to P. vivax (Mann-Whitney U test; Z score = 2.4) ( Supplementary Table 5 ). Although neither of these enrichments was statistically significant after correction for multiple testing, this pattern bears further exploration when sequence data from more P. vivax genomes become available.
As expected, we observed enormous diversity in the vir gene family, the members of which are variably expressed and encode proteins that are exported to the host cell surface for the purpose of evading the host adaptive immune response 20 . Of the 313 vir genes included in the Salvador I reference assembly, less than a third are also observed in the four new assemblies (Fig. 3b) . Unexpectedly, we encountered 15 'ultra-conserved' vir genes that were present in all assemblies and showed very low SNP diversity; in particular, one locus (PVX_113230) was invariant and showed the highest similarity (70% protein sequence identity) of any vir to the homologous kir gene family in Plasmodium knowlesi, a zoonotic parasite (Fig. 3c) . Unlike most vir genes, this locus also exhibits conserved synteny in more distantly related rodent malaria parasites. These attributes suggest that PVX_113230 is likely the founder of the vir family in the P. vivax lineage, and the lack of polymorphism suggests that the protein it encodes performs an ancestral role rather than host immune modulation. The molecular function of PVX_113230 could be related to erythrocyte invasion, as suggested by its distinct expression profile in erythrocytes relative to most vir genes 21 (Supplementary Fig. 4) .
This global census of genomic diversity in P. vivax has uncovered an unexpected degree of genetic polymorphism, much of which may 
